DNA Day commemorates the successful completion of the Human Genome Project and discovery of DNA’s double helix
On April 25 known as DNA Day, is a day that commemorates the successful completion of the Human…
Eli Lilly and Company launched Symbyax in the U.S.
On Apr. 19, 2004, Eli Lilly and Company launched Symbyax in the U.S., the first and only Food…
Biotechnology | Diagnostics | Disease | Environmental | NIH | Non-Profit Research | Oncology | Therapeutics
The National Center for Vermiculite and Asbestos-Related Cancers was established
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute of Neuroscience at Yale University
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute for Brain Science at Columbia University Medical Center
On Mar. 10, 2004, The Kavli Foundation announced a $7.5 million award to establish a Kavli Institute for…
The Kavli Foundation established the Kavli Institute for Brain and Mind at the University of California, San Diego
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
The National incident Management System was established to coordinate response for public health incidents
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
Biotechnology | FDA | Medicine | Oncology | Therapeutics
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
Biotechnology | FDA | Oncology | Therapeutics
The monoclonal antibody cetuximab (Erbitux) was approved by the FDA for the treatment of metastatic colorectal cancer
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved oxaliplatin (Eloxatin) for use in the treatment of advanced colorectal cancer
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
The Delaware BioScience Association was founded
In 2004, representatives from a cross-section of bioscience enterprises met under the direction of Governor Ruth Ann Minner…
The University of Georgia Cancer Center was established
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…
Medtronic moved into new world headquarters in Fridley, Minnesota
In 2004, Medtronic moved into new world headquarters in Fridley, Minnesota. At that time, Medtronic operated from more…
Siteman Cancer Center was designated a Comprehensive Cancer Center by the NCI
On Jan. 20, 2005, the Siteman Cancer Center received National Cancer Institute (NCI) designation as a Comprehensive Cancer…
Touro University was founded
In 2004, Touro University Nevada (TUN), located in Henderson, was founded as a private, non-profit institution of higher…
OMRF opened the state’s first small animal magnetic resonance imaging facility
In 2004, the Oklahoma Medical Research Foundation (OMRF) opened the state’s first small animal magnetic resonance imaging facility….
World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
The Huntsman Cancer Center Hospital opened
On Jun. 21, 2004, the Huntsman Cancer Center Hospital was dedicated featuring a full-field digital mammography unit, a…
William Hagopian launched The Environmental Determinants of Diabetes in the Young study
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
Anabolic Steroid Control Act banned OTC steroid precursors and increased penalties for illegal steroids
In 2004, the U.S. Congress passed the Anabolic Steroid Control Act which enacted a ban on over-the-counter steroid…
FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New Medical Products”
In 2004, the FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New…
The Emergency Use Authorization program was established
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
Biotechnology | Diagnostics | FDA | NIH | Oncology | Therapeutics
The National Cancer Institute collaborated with the Department of Health and Human Services to establish National Network of Tobacco Cessation Quitlines
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
The Scripps Research Institute announced the establishment of a major science center in Palm Beach County, Florida
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
The Allen Brain Atlas project was established with $100 million and named for its founder Paul G Allen
On Sept. 16, 2003, The Allen Institute for Brain Science, a division of the Allen Institute, was established…